Saving Face

Article

At sites where cosmesis is critical, such as on the face, use aluminum chloride and pressure for hemostasis rather than electrocautery.

At sites where cosmesis is critical, such as on the face, use aluminum chloride and pressure for hemostasis rather than electrocautery.

-Benjamin Barankin, MD
    Toronto

 

More Pointers >>

Recent Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
Healthy Low-Carb or Low-Fat Diets Linked to Lower CVD Risk: Daily Dose / image credit: ©New Africa/AdobeStock

Healthy Low-Carb or Low-Fat Diets Linked to Lower CVD Risk: Daily Dose

Sydney Jennings
June 19th 2025
Article

Your daily dose of the clinical news you may have missed.

The Weekly Dose: Cannabis, Contraceptives, and Advances in Alzheimer Disease and Gonorrhea Treatment

The Weekly Dose: Cannabis, Contraceptives, and Advances in Alzheimer Disease and Gonorrhea Treatment

Sydney Jennings
June 11th 2025
Podcast

Clinical insights on cannabis and dementia, hormonal contraceptives and postpartum depression, the FDA-approved blood test for Alzheimer disease, more.

PATHFINDER 2 Study Shows Improved Performance of Galleri Multicancer Detection Test / image credit GRAIL

PATHFINDER 2 Study Shows Improved Performance of Galleri Multicancer Detection Test

Grace Halsey
June 19th 2025
Article

GRAIL announced that both cancer detection and positive predictive value with Galleri were substantially higher than in the earlier published PATHFINDER study.

The Weekly Dose: Advancements in Colonoscopy, AI for Mammography, and Telemedicine Antibiotic Stewardship

The Weekly Dose: Advancements in Colonoscopy, AI for Mammography, and Telemedicine Antibiotic Stewardship

Sydney Jennings
June 4th 2025
Podcast

Discover the latest breakthroughs in clinical research, from at-home cancer screening to AI advancements in mammography, shaping future healthcare practices.

Atogepant Superior to Topiramate for Migraine Prevention in Phase 3 Head-to-Head TEMPLE Study / image credit ©mopic/shutterstock.com

Atogepant Superior to Topiramate for Migraine Prevention in Phase 3 Head-to-Head TEMPLE Study

Grace Halsey
June 18th 2025
Article

The superior tolerability and efficacy of the CGRP-targeting atogepant supports recent calls from the AHS to consider the class as first-line preventive therapy for migraine.

/ image credit Cathy Goldstein, MD Courtesy of Michigan Neuroscience Institute

Validation Study of SANSA Home Sleep Apnea Test Published in Frontiers in Neurology, Huxley Medical Announced

Grace Halsey
June 18th 2025
Article

Huxley Medical's SANSA home sleep apnea test matched traditional PSG in accuracy and significantly simplifies OSA assessment and diagnosis for patients and HCPs.

© 2025 MJH Life Sciences

All rights reserved.